Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD

被引：3
|
作者：
Denadai, Rafael [1 ]
Teixeira, Fabio V. [1 ]
Saad-Hossnethe, Rogerio [1 ]
机构：
[1] Univ State Sao Paulo UNESP, Sch Med Sci, Dept Surg, Div Coloproctol, BR-17516707 Sao Paulo, Brazil
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2012年 / 9卷 / 12期
关键词：
INFLAMMATORY-BOWEL-DISEASE; NECROSIS FACTOR THERAPY; INFLIXIMAB; ONSET;
D O I：
10.1038/nrgastro.2012.125-c1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：744 / 744
页数：1
相关论文
共 50 条
  • [31] Editorial: is there a role for monitoring intermediate anti-TNF drug concentrations in IBD?
    Rakowsky, Shana
    Cheifetz, Adam S.
    Papamichael, Konstantinos
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1049 - 1050
  • [32] Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working
    Adler, Jeremy
    Lee, Grace J.
    Singer, Andrew A. M.
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 322 - 324
  • [33] Development of psoriasis in IBD patients under TNF-antagonist therapy is associated neither with anti-TNF-antagonist antibodies nor trough levels
    Protic, Marijana
    Schoepfer, Alain
    Yawalkar, Nikhil
    Vavricka, Stephan
    Seibold, Frank
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (12) : 1482 - 1488
  • [34] Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy
    Dahmus, Jessica
    Rosario, Michelle
    Clarke, Kofi
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2020, 13 : 339 - 350
  • [35] AN AUDIT OF ADHERENCE TO ANTI-TNF THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Duncan, J.
    Sastrillo, M.
    Baker, J.
    Younge, L.
    Anderson, S.
    Lindsay, J.
    Sanderson, J.
    Irving, P.
    GUT, 2011, 60
  • [36] Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease
    Andrisani, G.
    Guidi, L.
    Papa, A.
    Armuzzi, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (07) : 890 - 901
  • [37] Functional Molecular Network Analysis Enables Prediction of Response to Vedolizumab Therapy in Anti-TNF Refractory IBD Patients
    Breidert, Matthias
    Eftekhari, Pierre
    Louis, Francois
    Rotoiu, Claudia
    Rath, Timo
    Neurath, Markus F.
    Atreya, Raja
    CROHNS & COLITIS 360, 2020, 2 (02)
  • [38] Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy
    Reiss, Zuzana
    Rob, Filip
    Kolar, Martin
    Schierova, Dagmar
    Kreisinger, Jakub
    Jackova, Zuzana
    Roubalova, Radka
    Coufal, Stepan
    Mihula, Martin
    Thon, Tomas
    Bajer, Lukas
    Novakova, Michaela
    Vasatko, Martin
    Kostovcikova, Klara
    Galanova, Natalie
    Lukas, Milan
    Kverka, Miloslav
    Hercogova, Jana Tresnak
    Tlaskalova-Hogenova, Helena
    Zakostelska, Zuzana Jiraskova
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 12
  • [39] New choices, new challenges: Anti-TNF versus anti-integrin molecule therapy in IBD
    van Langenberg, Daniel R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 10 - 11
  • [40] Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study
    Alharbi, Othman
    Aljebreen, Abdulrahman M.
    Azzam, Nahla A.
    Almadi, Majid A.
    Saeed, Maria
    HajkhderMullaissa, Baraa
    Asiri, Hassan
    Almutairi, Abdullah
    AlRuthia, Yazed
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
12345